Scilex Holding Company (SCLX)’in fiyatı nedir?

Scilex Holding Company (SCLX)’in fiyatı $5.61’dir

Scilex Holding Company (SCLX)’in piyasa değeri nedir?

Scilex Holding Company (SCLX)’in piyasa değeri $47.65M’dir.

Scilex Holding Company (SCLX) Temettü Verimi

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.

Yıl	Temettü Verimi	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Temettü Verimi

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Temettü Verimi	Ülke
Eli Lilly and Company LLY.US	0.57%	US
Johnson & Johnson JNJ.US	2.01%	US
AbbVie Inc. ABBV.US	2.74%	US
Roche Holding AG RO.SW	2.69%	CH
Merck & Co., Inc. MRK.US	2.47%	US

Şirket

Temettü Verimi

Ülke

Eli Lilly and Company

LLY.US

0.57%

Johnson & Johnson

JNJ.US

2.01%

AbbVie Inc.

ABBV.US

2.74%

Roche Holding AG

RO.SW

2.69%

Merck & Co., Inc.

MRK.US

2.47%

Scilex Holding Company

SCLX

Kategori